BioNTech SE (BNTX) Share-based Compensation (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Share-based Compensation data on file, last reported at $28.1 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation rose 11.71% year-over-year to $28.1 million; the trailing twelve-month figure through Dec 2025 stood at $120.3 million (up 9.83% YoY), and the FY2025 full-year result was $120.0 million, up 11.28% from the prior year.
• Share-based Compensation slipped to $28.1 million in Q4 2025, from $32.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $73.6 million in Q3 2021 to a low of $20.87 in Q1 2021.
• A 5-year average of $26.1 million and a median of $22.9 million in 2022 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 269441191.15% in 2021, while the deepest fall reached 100.0% in 2021.
• Tracing BNTX's Share-based Compensation over 5 years: stood at $23.5 million in 2021, then fell by 3.42% to $22.6 million in 2022, then tumbled by 32.54% to $15.3 million in 2023, then jumped by 64.36% to $25.1 million in 2024, then gained by 11.71% to $28.1 million in 2025.
• Business Quant data shows BNTX's Share-based Compensation at $28.1 million in Q4 2025, $32.6 million in Q3 2025, and $36.3 million in Q2 2025.